GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with ...

As the markets for weight-loss drugs develop, pharma companies are having to adapt in search of the next big thing.

David Hallal, Scholar Rock CEO, joins 'Fast Money' to talk its recent drug study results that found its drug taken in ...

Amgen's long-acting experimental obesity drug MariTide needs to be given at a low starting dose to limit side effects like ...

Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.

Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...

Compounded weight loss drugs have been mostly off the market for about a month, but the weight loss drug industry remains as ...

Novo Nordisk had been providing Hims & Hers with the FDA-approved Wegovy, an injectable semaglutide used for weight loss ...

Patients who took an experimental drug from Eli Lilly & Co. together with Novo Nordisk A/S’s Wegovy maintained muscle while ...

Doctors say there have been a number of developments with new weight loss drugs, which could make them easier for patients to ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

A Chinese-developed GLP-1 drug is as effective as Ozempic or Zepbound, clinical trial says ...